San Francisco played host to the biotech world, and we were there to bring all the news and views across the industry to you, our readers
23-Jun-2016 - Automated systems and reducing hiring time will be crucial in revamping the US FDA’s “antiquated” HR systems, says Commissioner Robert Califf.
22-Jun-2016 - The non-proprietary naming debate is “almost a little comical” says Sandoz, which argues a proposed four-letter suffix adds little to aid post-marketing surveillance of biological products.
17-Jun-2016 - Manufacturing complexity will keep both the number of biosimilar players and pricing discounts low, said an expert panel at BIO last week.
14-Jun-2016 - Differentiated technologies buoyed by the recent $600m conjugation deal with Roche is driving Catalent’s biologics business, the firm told Biopharma-Reporter at BIO.
13-Jun-2016 - Expect industry guidance on product communication soon says US FDA Commissioner Robert Califf, though a more pragmatic approach to social media will be taken.
10-Jun-2016 - Single-use technology is driving a new era in vaccine development says PnuVax which has acquired IP from GE Healthcare to produce an inactivated yellow fever vaccine.
08-Jun-2016 - The new 50,000 square foot facility in Lexington, MA will be dedicated to late phase development and commercial manufacturing for advanced cell and gene therapies.
08-Jun-2016 - With problems in forecasting capacity demand, biopharma is looking to a number of new models from third-party manufacturers according to Patheon.
07-Jun-2016 - A new $60m facility at a MSD site in Ireland will offer Fujifilm Diosynth customers 20,000L of microbial biologics capacity in a collaboration between the two firms.
07-Jun-2016 - [View the story "Live from 2016 BIO International Convention " on Storify]